Sangamo Therapeutics SGMO Stock Momentum Analysis Sangamo Therapeutics posts 797 downside EPS miss RENX RenX Enterprises reports stable quarterly performance forecasts accelerated customer acquisition for upcoming fiscal periods POCI Precision falls 119 after Q1 2026 earnings report a 023 per share loss with no analyst estimates available Baidu BIDU Market Conditions Baidu posts 126 EPS beat fueled by robust AI segment growth MRNO Murano CEO highlights promising crossborder investment opportunities as key 2024 strategic growth priority